Insulet Corporation ($PODD) Stock Forecast: Up 5.7% Today

What is Insulet Corporation?

Insulet Corporation (PODD) is a medical device company specializing in insulin delivery systems, notably the Omnipod Insulin Management System. The market sentiment towards Insulet has been positive today.

Why is Insulet Corporation going up?

PODD stock is up 5.7% on Aug 8, 2025 15:01

• Insulet (PODD) posted robust Q2 results, surpassing revenue projections and revising its annual sales forecast upwards. This strong financial showing likely bolstered investor confidence in the company's growth potential, contributing to the stock's favorable performance.
• The company's consistent outperformance over the past ten years, as noted in insights on its historical stock returns, may have also enticed investors looking for sustainable growth opportunities.
• The market's optimistic response to Insulet's earnings beat and raised guidance indicates confidence in the adoption of its insulin pump products, especially the Omnipod 5, pointing towards a promising future performance for the company.

PODD Price Chart

PODD Technical Analysis

PODD News

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 - Insulet ( NASDAQ:PODD )

Q2 revenue rises 32.9% Y/Y to $649.1 million, beating estimates and topping guidance range. Insulet raises FY25 sales outlook to $2.57 billion-$2.63 billion, above prior view of $2.47 billion-$2.53 billion. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily.

https://www.benzinga.com/markets/earnings/25/08/46973049/insulet-lifts-annual-forecast-on-increased-adoption-for-insulin-pump-omnipod-5

Insulet ( PODD ) Surpasses Q2 Earnings and Revenue Estimates

Insulet (PODD) delivered earnings and revenue surprises of +25.81% and +5.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2678075/insulet-podd-surpasses-q2-earnings-and-revenue-estimates

Curious about Insulet ( PODD ) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

https://www.zacks.com/stock/news/2667418/curious-about-insulet-podd-q2-performance-explore-wall-street-estimates-for-key-metrics

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years - Insulet ( NASDAQ:PODD )

Insulet PODD has outperformed the market over the past 10 years by 12.07% on an annualized basis producing an average annual return of 23.62%. Currently, Insulet has a market capitalization of $20.05 billion.

https://www.benzinga.com/insights/news/25/08/46810413/heres-how-much-you-would-have-made-owning-insulet-stock-in-the-last-10-years

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.2% Today

Duolingo Inc. ($DUOL) Stock Forecast: Up 5.9% Today

Roblox Corp ($RBLX) Stock Forecast: Up 5.2% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 7.2% Today

Sonos Inc. ($SONO) Stock Forecast: Up 5.4% Today

Sunrun Inc. ($RUN) Stock Forecast: Down 6.5% Today

Royal Caribbean Cruises Ltd. ($RCL) Stock Forecast: Up 5.1% Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Northrop Grumman Corporation ($NOC) Stock Forecast: Up 1.2% Today

Arbitrum ($ARB) Crypto Forecast: Down 6.0% Today

Insulet Corporation Price History

20.11.2024 - PODD Stock was up 5.1%

• Insulet (PODD) displayed a solid bullish movement in the market today.
• Insulet's impressive 15-year performance, exceeding the market by 9.66% annually, was noted.
• The company's longstanding success and market outperformance likely influenced the positive movement of PODD today.
• Investor optimism regarding Insulet's future growth potential is believed to have bolstered buying activity and propelled the stock price upwards.

09.04.2025 - PODD Stock was up 14.4%

• Exceeded earnings and revenue expectations for Q1, indicating strong financial performance.
• The positive surprise in earnings and revenues suggests that the company's insulin delivery systems are in high demand.
• Investors may be optimistic about the future prospects of Insulet (PODD) based on these strong financial results.
• The bullish movement in the stock price could be attributed to the market's positive reaction to the company's impressive performance in Q1.

08.10.2024 - PODD Stock was up 13.3%

• Q3 earnings and revenues of Insulet (PODD) exceeded analysts' estimates, reflecting strong financial performance.
• The initiation of coverage on a bullish note by a top Wall Street analyst may have bolstered investor confidence in the stock.
• Insulet's growth strategies and focus on innovation, including a direct-to-consumer advertising campaign for Omnipod, likely supported the stock's upward momentum.
• Detailed insights into key metrics by Wall Street analysts could have further improved the sentiment towards Insulet's future outlook, driving the bullish movement in the stock.

24.03.2025 - PODD Stock was up 5.2%

• Insulet (PODD) has delivered impressive performance over the last 15 years, consistently outperforming the market by 10.59% on an annual basis with an average return of 21.0%.
• The stock's upward movement today could be linked to Insulet's sustained growth and solid market capitalization of $17.14 billion.
• Investor optimism regarding Insulet's future within the medical device sector may have heightened, resulting in increased buying activity and pushing the stock price upwards.

21.01.2025 - PODD Stock was down 1.6%

• Insulet (PODD) recently announced positive earnings and revenue figures that exceeded expectations, but the stock saw a decline in value.
• This decline could be attributed to investors selling off their shares to lock in profits, possibly indicating high expectations that were not fully met.
• Concerns about future growth potential or guidance provided by the company may have also influenced the downward trajectory of the stock.
• External market conditions or general sentiments within the healthcare industry might have played a role in the stock's negative performance.

07.07.2025 - PODD Stock was up 9.2%

• Insulet (PODD) stock experienced a strong bullish movement today, possibly driven by positive market sentiment and investor optimism.
• The anticipation of strong Q2 performance and earnings growth expectations by financial analysts could have contributed to the bullish momentum.
• The long-term outperformance of Insulet stock over the past decade, with an average annual return of 23.62%, may have attracted investors seeking growth opportunities.
• Overall, the combination of positive market expectations, strong historical performance, and an upcoming earnings report could have fueled the bullish movement in Insulet (PODD) stock today.

07.07.2025 - PODD Stock was up 5.7%

• In Q2, Insulet (PODD) surpassed both earnings and revenue forecasts, demonstrating robust financial performance.
• The stock has consistently outperformed the market over the last ten years, with a notable average annual return, indicating a reliable performance history.
• The stock's price increase today is likely influenced by the favorable quarterly results and sustained market outperformance.
• Investors show confidence in Insulet's growth potential, backed by its strong financial performance and market positioning in the diabetes management sector.

18.01.2025 - PODD Stock was up 0.8%

• Insulet (PODD) had a strong bullish movement today, potentially driven by positive insights from analysts regarding the company's Q4 earnings.
• The market may have reacted positively to projections for key metrics, indicating a strong performance for the quarter ended December 2024.
• Investors might be optimistic about the company's growth prospects and financial health, leading to increased buying interest in Insulet's stock.
• Overall, the bullish movement in PODD could be attributed to favorable expectations surrounding the company's financial performance and strategic direction.

14.10.2024 - PODD Stock was down 5.1%

• Despite Insulet's positive Q3 earnings and revenue beat, the stock experienced a bearish movement, indicating that the market may have had higher expectations priced in.
• The positive performance in the third quarter could have already been factored into the stock price prior to the earnings release, leading to a "sell the news" reaction from investors.
• Investors may have been looking for even more optimistic guidance or future outlook from Insulet, causing disappointment and triggering a sell-off in the stock.
• The overall market sentiment or external factors could have influenced the bearish movement in Insulet's stock, despite the positive earnings report.

25.01.2025 - PODD Stock was down 5.9%

• Despite posting strong Q4 earnings and revenues exceeding expectations, Insulet Corporation (PODD) saw a downtrend in its stock price.
• Profit-taking by investors following a robust performance may have triggered the negative market response, causing a temporary decline.
• Concerns about future growth potential or external economic factors affecting the healthcare sector could have spurred the selling pressure on Insulet's stock.
• Shifts in market sentiment possibly driven by factors beyond the company's performance, such as overall market trends or geopolitical events, may have contributed to today's bearish movement in PODD stock.

08.07.2025 - PODD Stock was up 5.7%

• Insulet (PODD) posted robust Q2 results, surpassing revenue projections and revising its annual sales forecast upwards. This strong financial showing likely bolstered investor confidence in the company's growth potential, contributing to the stock's favorable performance.
• The company's consistent outperformance over the past ten years, as noted in insights on its historical stock returns, may have also enticed investors looking for sustainable growth opportunities.
• The market's optimistic response to Insulet's earnings beat and raised guidance indicates confidence in the adoption of its insulin pump products, especially the Omnipod 5, pointing towards a promising future performance for the company.

29.03.2025 - PODD Stock was down 5.4%

• The decrease in Insulet's stock (PODD) value is possibly linked to a recent downgrade by a prominent Wall Street analyst, triggering a change in market sentiment.
• Despite its track record of strong performance and consistent annual returns, investors seem to be responding to the recent rating downgrade and repositioning their investments.
• With a market capitalization of $17.14 billion, Insulet holds a substantial position in the medical device sector. However, current influences like analyst evaluations can still impact its stock performance in the short term.